This fact is highlighted by a markedly higher hazard ratio and decreased survival in breast cancer patients (the cancer Genome Atlas data base) with higher expression signature of hGH, hGHR, and hPRLR together, compared to hGHR or hPRLR alone (Fig. S7). Here, GH1 is linked to breast carcinoma.